Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine to evaluate safety and tolerability of CPL304110
when administered once daily to adults with advanced solid malignancies.
Phase:
Phase 1
Details
Lead Sponsor:
Celon Pharma SA
Collaborator:
National Center for Research and Development, Poland